Clinical Trial Details
— Status: Terminated
Administrative data
| NCT number |
NCT04469452 |
| Other study ID # |
20-0317 |
| Secondary ID |
|
| Status |
Terminated |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
September 1, 2020 |
| Est. completion date |
November 28, 2023 |
Study information
| Verified date |
November 2023 |
| Source |
University of Colorado, Denver |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
This study plans to test the accuracy of a new device (the Apollo EE Device) that measures
resting energy expenditure (REE) using only oxygen consumed (VO2). Findings from this study
will help determine how this new device compares to the gold standard, indirect calorimetry,
which measures REE using VO2 and carbon dioxide production (VCO2). Findings may help develop
less expensive and more accessible means of measuring energy expenditure.
Description:
The gold standard for measuring resting metabolic rate (RMR) is metabolic carts that measure
oxygen consumption (VO2) and carbon dioxide production (VCO2). The energy equivalent of VO2
ranges from ~4.7-5.0 kcals/L, depending on the ratio of carbohydrate, fat, and protein
oxidized. However, RMR can be measured based solely on VO2, because VCO2 has a relatively
small effect on energy expenditure estimation. A device that measures RMR based on VO2 and
eliminates the need for measuring VCO2 could provide a simple and less expensive alternative
to metabolic carts and may have important clinical applications. The overarching goal of this
proposal is to validate such a metabolic system by comparing its ability to accurately
measure RMR against a metabolic cart.